Clinical Trials Logo

Recurrent, Refractory, or High Risk Leukemias clinical trials

View clinical trials related to Recurrent, Refractory, or High Risk Leukemias.

Filter by:
  • None
  • Page 1

NCT ID: NCT02670525 Recruiting - Clinical trials for Recurrent, Refractory, or High Risk Leukemias

Matched Targeted Therapy For High-Risk Leukemias

Start date: February 2016
Phase: N/A
Study type: Interventional

This research study is seeking to gain new knowledge about Recurrent, Refractory, or High Risk Leukemias in children and young adults. This study is evaluating the use of specialized testing called leukemia profiling. Once the profiling is performed, the results are evaluated by an expert panel of physicians, scientists and pharmacists. This may result in a recommendation for a specific cancer therapy or a clinical trial called matched targeted therapy (MTT). The results of the leukemia profiling and, if applicable, the MTT recommendation will be communicated to the participant's primary oncologist.